...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Early Warning Report

NBB - Things are always so quiet in the ZCC front that it is pretty hard to guess when some development might happen. It could be any time or whenever. 2 1/2 years ago, we were told from the top that it would happen over the next couple of months so who knows?

As far on the effect on RVX share price, I'm not sure there would be a lot of impact. I hope so though! RVX/ZCC(ZEL) have been pushed to the medical world and pharmas but don't seem to have been promoted much toward the investment world. With RVX sitting on the TSX and ZCC nowhere and little promotion, I wonder how many even know the connection if they even know these companies exist. I wouldn't count on much impact unless things change on that front.

Share
New Message
Please login to post a reply